Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008

• Record Nr.: UNINA9910145965203321
• Pubbl/distr/stampa: Geneva, : World Health Organization, Stop TB Department, c2008
• ISBN: 1-282-05799-5; 9786612057991; 92-4-068353-4
• Edizione: [Emergency update.]
• Descrizione fisica: 1 online resource (270 p.)
• Disciplina: 615.58
• Soggetti: Antitubercular agents; Comorbidity - Treatment; Highly active antiretroviral therapy; HIV infections - Chemotherapy; Multidrug-resistant tuberculosis - Chemotherapy; Multidrug-resistant tuberculosis - Prevention
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations; CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:; training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care; ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER
• Sommario/riassunto: The emergence in 2006 of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, are serious threats to global public health and jeopardizes efforts to effectively control the disease. These important developments and the availability of new evidence related to the diagnosis and management of drug-resistant tuberculosis have mandated an urgent update of existing guidelines. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency updated edition 2008 replaces previous publications by the Wor